Evommune, Inc. (EVMN)
23.18
+0.26
(+1.13%)
USD |
NYSE |
May 11, 16:00
23.48
+0.30
(+1.29%)
After-Hours: 20:00
Evommune Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 20.17% |
| Moderna, Inc. | -345.2% |
| Apogee Therapeutics, Inc. | -- |
| Vertex Pharmaceuticals, Inc. | 34.24% |
| Kymera Therapeutics, Inc. | -201.5% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -48.45% |
| Return on Invested Capital | -52.97% |
| Return on Net Operating Assets | -2.43K% |